|
While researching and writing a feature article on presbyopia for the June issue of Vision Monday, I remembered a novel device called the Grolman Fitting System that was once used for fitting patients with progressive lenses. It was, excuse the pun, progressive for its time, though it has since been replaced with modern, digital technologies. Here’s a brief history of the device, drawn from an article I wrote about 25 years ago.
Read More
|
 |
VSP Ventures acquires two practices, See & Be Seen Frame Benefit for Opening Your Eyes Scholarship starts June 18, ECP’s gross revenue increased substantially, Jobson Tracker says, consumer interest in vision benefits is rising and Midwest Vision Partners announces two new partnerships all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.
|
|
|
|
|
|
 |
|
KIBBUTZ SHAMIR, Israel—In late May, just ahead of a celebration to mark the 50th anniversary of Shamir Optical Industry, Vision Monday met with leaders of the company at their corporate headquarters here. In exclusive, wide ranging video interviews, three of Shamir’s top executives—Yagen Moshe, CEO and president, Raanan Naftalovich, CEO and president of Shamir North America and Zohar Katzman, chief technical officer—discussed how the company has established and maintains its position as a vision technology innovator on a global scale.
Read More
|
 |
|
Did you follow the optical news this week? Take VM’s News Quiz to see how much you know. This week's quiz takes a look at a vision wellness study, B+L’s cataract awareness program and EGOT winners.
Click here to take the quiz.
|
This Scrabble tile name plaque is a fun, unexpected addition to your desk. You can personalize and purchase it on Etsy here. #WeShareIt
|
|
|
PORT JEFFERSON, N.Y.—Christian Guardino is many things: a New Yorker, a musician, an American Idol finalist and a person born with Leber Congenital Amaurosis. At age 13, Guardino underwent experimental gene therapy to protect his eyesight. He said, “This disease causes inevitable blindness because there is a gene that is missing in the eye, because that gene is missing, it is not producing proteins that your cells need to live, and they slowly die off to cause complete and inevitable blindness.” Through gene therapy, doctors were able to copy the missing gene and inject it into Guardino’s eye.
Read More
|
Interested in more from VisionMonday and VMail? Click here to subscribe to our other e-newsletters. |
|
VMail Weekend is published by Jobson Medical Information LLC, 395 Hudson Street, New York, NY 10014.
To subscribe to other JMI newsletters or to manage your subscription, click here.
|
|
|